Starting July 1, 2026, the Medicare GLP-1 Bridge program will give eligible Part D plan members access to Foundayo , Wegovy (injection or tablet), or Zepbound (KwikPen ) weight loss medications for a $50 copayment for each 30-day supply
There is also a growing distinction between indications within coverage frameworks
Members get access to detailed retatrutide dose schedules , dosage calculators , and expert guidance that takes the guesswork out of peptide research
He also thinks coverage is the right investment economically, estimating that the North Carolina Medicaid program spends about a billion dollars a year on obesity-related expenses
These effects make GLP-1 injections an effective option for weight loss, as they help control hunger, reduce cravings, and encourage healthier eating habits
Titration schedule: Each dose escalation occurs at four-week intervals minimum